Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.61
NYSE:ABC's Cash to Debt is ranked higher than
50% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.61 vs. NYSE:ABC: 0.61 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:ABC' s Cash to Debt Range Over the Past 10 Years
Min: 0.09  Med: 0.68 Max: 1.38
Current: 0.61
0.09
1.38
Equity to Asset 0.06
NYSE:ABC's Equity to Asset is ranked lower than
96% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. NYSE:ABC: 0.06 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:ABC' s Equity to Asset Range Over the Past 10 Years
Min: 0.01  Med: 0.2 Max: 0.38
Current: 0.06
0.01
0.38
Interest Coverage 10.57
NYSE:ABC's Interest Coverage is ranked lower than
51% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.09 vs. NYSE:ABC: 10.57 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:ABC' s Interest Coverage Range Over the Past 10 Years
Min: 3.77  Med: 14 Max: N/A
Current: 10.57
F-Score: 6
Z-Score: 4.84
M-Score: -2.61
WACC vs ROIC
6.98%
37.38%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 1.04
NYSE:ABC's Operating margin (%) is ranked lower than
77% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.02 vs. NYSE:ABC: 1.04 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:ABC' s Operating margin (%) Range Over the Past 10 Years
Min: 0.31  Med: 1.21 Max: 1.67
Current: 1.04
0.31
1.67
Net-margin (%) 0.97
NYSE:ABC's Net-margin (%) is ranked lower than
75% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.85 vs. NYSE:ABC: 0.97 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:ABC' s Net-margin (%) Range Over the Past 10 Years
Min: -0.1  Med: 0.71 Max: 0.97
Current: 0.97
-0.1
0.97
ROE (%) 87.97
NYSE:ABC's ROE (%) is ranked higher than
98% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.93 vs. NYSE:ABC: 87.97 )
Ranked among companies with meaningful ROE (%) only.
NYSE:ABC' s ROE (%) Range Over the Past 10 Years
Min: -10.74  Med: 18.36 Max: 104.01
Current: 87.97
-10.74
104.01
ROA (%) 4.55
NYSE:ABC's ROA (%) is ranked higher than
65% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.80 vs. NYSE:ABC: 4.55 )
Ranked among companies with meaningful ROA (%) only.
NYSE:ABC' s ROA (%) Range Over the Past 10 Years
Min: -0.56  Med: 3.82 Max: 4.8
Current: 4.55
-0.56
4.8
ROC (Joel Greenblatt) (%) 127.03
NYSE:ABC's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.27 vs. NYSE:ABC: 127.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:ABC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 36.42  Med: 130.02 Max: 184.88
Current: 127.03
36.42
184.88
Revenue Growth (3Y)(%) 20.30
NYSE:ABC's Revenue Growth (3Y)(%) is ranked higher than
86% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.00 vs. NYSE:ABC: 20.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:ABC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.9  Med: 16 Max: 28.5
Current: 20.3
7.9
28.5
EBITDA Growth (3Y)(%) 23.30
NYSE:ABC's EBITDA Growth (3Y)(%) is ranked higher than
79% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. NYSE:ABC: 23.30 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:ABC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -19.7  Med: 16.5 Max: 26.9
Current: 23.3
-19.7
26.9
EPS Growth (3Y)(%) 44.40
NYSE:ABC's EPS Growth (3Y)(%) is ranked higher than
89% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.30 vs. NYSE:ABC: 44.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:ABC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -21.8  Med: 20.4 Max: 44.4
Current: 44.4
-21.8
44.4
» NYSE:ABC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

ABC Guru Trades in Q4 2015

George Soros 3,900 sh (New)
Jim Simons 1,410,100 sh (+80.50%)
Ray Dalio 58,485 sh (+23.27%)
Ken Fisher 112,848 sh (-4.49%)
Paul Tudor Jones 2,200 sh (-46.34%)
Keeley Asset Management Corp 29,021 sh (-49.34%)
Jeremy Grantham 10,700 sh (-75.09%)
» More
Q1 2016

ABC Guru Trades in Q1 2016

First Pacific Advisors 93,690 sh (New)
Joel Greenblatt 6,083 sh (New)
Leucadia National 2,900 sh (New)
Ray Dalio 243,992 sh (+317.19%)
Paul Tudor Jones 5,000 sh (+127.27%)
George Soros Sold Out
Jeremy Grantham Sold Out
Ken Fisher 110,647 sh (-1.95%)
Jim Simons 1,239,400 sh (-12.11%)
Keeley Asset Management Corp 14,490 sh (-50.07%)
» More
Q2 2016

ABC Guru Trades in Q2 2016

Arnold Van Den Berg 82,350 sh (New)
Steven Cohen 389,600 sh (New)
David Einhorn 535,000 sh (New)
Joel Greenblatt 195,368 sh (+3111.70%)
Paul Tudor Jones 48,153 sh (+863.06%)
First Pacific Advisors 177,270 sh (+89.21%)
Ray Dalio 319,092 sh (+30.78%)
Jim Simons Sold Out
Leucadia National Sold Out
Ken Fisher 98,314 sh (-11.15%)
Keeley Asset Management Corp 10,966 sh (-24.32%)
» More
Q3 2016

ABC Guru Trades in Q3 2016

Jim Simons 167,600 sh (New)
Joel Greenblatt 289,299 sh (+48.08%)
Keeley Asset Management Corp 11,006 sh (+0.36%)
David Einhorn Sold Out
Steven Cohen Sold Out
Arnold Van Den Berg 81,165 sh (-1.44%)
First Pacific Advisors 172,600 sh (-2.63%)
Ken Fisher 84,606 sh (-13.94%)
Paul Tudor Jones 24,768 sh (-48.56%)
Ray Dalio 102,192 sh (-67.97%)
» More
» Details

Insider Trades

Latest Guru Trades with ABC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 424210    SIC: 5122
Compare:OTCPK:SHTDF, NAS:HSIC, NYSE:CAH, NAS:PDCO, OTCPK:MAHLY, NYSE:PBH, NYSE:OMI, OTCPK:UDHCF, NYSE:MCK, NYSE:PMC, OTCPK:SNYR, OTCPK:NPHC, OTCPK:FZMD, OTCPK:SCVM » details
Traded in other countries:ABG.Germany,
AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada.

AmerisourceBergen Corp was incorporated in Delaware in 2001. It is a pharmaceutical sourcing and distribution services company. It serves healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel and provides drug distribution and related services designed to reduce costs and improve patient outcomes. It operates in two segments including Pharmaceutical Distribution Segment and Other. Pharmaceutical Distribution segment includes two operating segments such as operations of ABDC and AmerisourceBergen Specialty Group ("ABSG"). ABDC distributes offering of brand-name and generic pharmaceuticals (including specialty pharmaceutical products), over-the-counter healthcare products, home healthcare supplies and equipment, outsourced CSPs, and related services to variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. BSG, through a number of operating businesses, provides pharmaceutical distribution and additional services to physicians specializing in a variety of disease states, especially oncology, and to other healthcare providers, including hospitals and dialysis clinics. The other segment consists the AmerisourceBergen Consulting Services ("ABCS") operating segment, the World Courier operating segment, and the MWI operating segment. ABCS, through a number of operating businesses, provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers. MWI is an animal health distribution company in the United States and in the United Kingdom. MWI sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients and other products to customers in both the companion animal and production animal markets. The Company's national competitors are Cardinal Health, Inc. and McKesson Corporation. It is subject to oversight by various federal and state governmental entities and it is subject to and affected by a variety of federal and state laws, regulations and policies. The Company is subject to governmental laws and regulations.

Ratios

vs
industry
vs
history
P/E(ttm) 12.46
ABC's P/E(ttm) is ranked higher than
86% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.98 vs. ABC: 12.46 )
Ranked among companies with meaningful P/E(ttm) only.
ABC' s P/E(ttm) Range Over the Past 10 Years
Min: 10.28  Med: 17.91 Max: 1712.67
Current: 12.46
10.28
1712.67
Forward P/E 13.68
ABC's Forward P/E is ranked higher than
60% of the 10 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.68 vs. ABC: 13.68 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 12.46
ABC's PE(NRI) is ranked higher than
88% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.98 vs. ABC: 12.46 )
Ranked among companies with meaningful PE(NRI) only.
ABC' s PE(NRI) Range Over the Past 10 Years
Min: 9.93  Med: 15.49 Max: 1468
Current: 12.46
9.93
1468
Price/Owner Earnings (ttm) 6.75
ABC's Price/Owner Earnings (ttm) is ranked higher than
93% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.57 vs. ABC: 6.75 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ABC' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 4.68  Med: 11.14 Max: 502.53
Current: 6.75
4.68
502.53
P/B 8.13
ABC's P/B is ranked lower than
96% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.38 vs. ABC: 8.13 )
Ranked among companies with meaningful P/B only.
ABC' s P/B Range Over the Past 10 Years
Min: 1.67  Med: 3.27 Max: 35.62
Current: 8.13
1.67
35.62
P/S 0.12
ABC's P/S is ranked higher than
92% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.89 vs. ABC: 0.12 )
Ranked among companies with meaningful P/S only.
ABC' s P/S Range Over the Past 10 Years
Min: 0.07  Med: 0.14 Max: 0.2
Current: 0.12
0.07
0.2
PFCF 6.53
ABC's PFCF is ranked higher than
96% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.35 vs. ABC: 6.53 )
Ranked among companies with meaningful PFCF only.
ABC' s PFCF Range Over the Past 10 Years
Min: 4.64  Med: 9.97 Max: 50.52
Current: 6.53
4.64
50.52
POCF 5.59
ABC's POCF is ranked higher than
92% of the 24 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.25 vs. ABC: 5.59 )
Ranked among companies with meaningful POCF only.
ABC' s POCF Range Over the Past 10 Years
Min: 4.28  Med: 8.64 Max: 463.25
Current: 5.59
4.28
463.25
EV-to-EBIT 12.44
ABC's EV-to-EBIT is ranked higher than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.05 vs. ABC: 12.44 )
Ranked among companies with meaningful EV-to-EBIT only.
ABC' s EV-to-EBIT Range Over the Past 10 Years
Min: -154.4  Med: 9.9 Max: 354.8
Current: 12.44
-154.4
354.8
EV-to-EBITDA 9.89
ABC's EV-to-EBITDA is ranked higher than
71% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.07 vs. ABC: 9.89 )
Ranked among companies with meaningful EV-to-EBITDA only.
ABC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.9  Med: 9.05 Max: 732.4
Current: 9.89
5.9
732.4
PEG 4.48
ABC's PEG is ranked lower than
80% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.20 vs. ABC: 4.48 )
Ranked among companies with meaningful PEG only.
ABC' s PEG Range Over the Past 10 Years
Min: 0.6  Med: 1.29 Max: 24.52
Current: 4.48
0.6
24.52
Shiller P/E 37.35
ABC's Shiller P/E is ranked lower than
72% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 28.15 vs. ABC: 37.35 )
Ranked among companies with meaningful Shiller P/E only.
ABC' s Shiller P/E Range Over the Past 10 Years
Min: 16.27  Med: 28.57 Max: 84.91
Current: 37.35
16.27
84.91
Current Ratio 0.90
ABC's Current Ratio is ranked lower than
90% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.60 vs. ABC: 0.90 )
Ranked among companies with meaningful Current Ratio only.
ABC' s Current Ratio Range Over the Past 10 Years
Min: 0.9  Med: 1.17 Max: 1.45
Current: 0.9
0.9
1.45
Quick Ratio 0.48
ABC's Quick Ratio is ranked lower than
96% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.14 vs. ABC: 0.48 )
Ranked among companies with meaningful Quick Ratio only.
ABC' s Quick Ratio Range Over the Past 10 Years
Min: 0.43  Med: 0.52 Max: 0.66
Current: 0.48
0.43
0.66
Days Inventory 26.87
ABC's Days Inventory is ranked higher than
80% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.06 vs. ABC: 26.87 )
Ranked among companies with meaningful Days Inventory only.
ABC' s Days Inventory Range Over the Past 10 Years
Min: 22.26  Med: 24.94 Max: 26.87
Current: 26.87
22.26
26.87
Days Sales Outstanding 22.81
ABC's Days Sales Outstanding is ranked higher than
84% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 62.35 vs. ABC: 22.81 )
Ranked among companies with meaningful Days Sales Outstanding only.
ABC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.6  Med: 19.23 Max: 25.11
Current: 22.81
17.6
25.11
Days Payable 61.25
ABC's Days Payable is ranked lower than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 82.92 vs. ABC: 61.25 )
Ranked among companies with meaningful Days Payable only.
ABC' s Days Payable Range Over the Past 10 Years
Min: 39.24  Med: 45.28 Max: 61.25
Current: 61.25
39.24
61.25

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.76
ABC's Dividend Yield is ranked lower than
57% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.94 vs. ABC: 1.76 )
Ranked among companies with meaningful Dividend Yield only.
ABC' s Dividend Yield Range Over the Past 10 Years
Min: 0.11  Med: 1.02 Max: 1.97
Current: 1.76
0.11
1.97
Dividend Payout 0.22
ABC's Dividend Payout is ranked higher than
76% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.28 vs. ABC: 0.22 )
Ranked among companies with meaningful Dividend Payout only.
ABC' s Dividend Payout Range Over the Past 10 Years
Min: 0.03  Med: 0.11 Max: 0.78
Current: 0.22
0.03
0.78
Dividend Growth (3y) 17.40
ABC's Dividend Growth (3y) is ranked higher than
73% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.70 vs. ABC: 17.40 )
Ranked among companies with meaningful Dividend Growth (3y) only.
ABC' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 29.8 Max: 81.7
Current: 17.4
0
81.7
Forward Dividend Yield 1.85
ABC's Forward Dividend Yield is ranked lower than
56% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.09 vs. ABC: 1.85 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 5.71
ABC's Yield on cost (5-Year) is ranked higher than
63% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.77 vs. ABC: 5.71 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ABC' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.36  Med: 3.33 Max: 6.43
Current: 5.71
0.36
6.43
3-Year Average Share Buyback Ratio 1.50
ABC's 3-Year Average Share Buyback Ratio is ranked higher than
85% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.10 vs. ABC: 1.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ABC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -24  Med: 4.3 Max: 9.9
Current: 1.5
-24
9.9

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.65
ABC's Price/Projected FCF is ranked higher than
97% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.38 vs. ABC: 0.65 )
Ranked among companies with meaningful Price/Projected FCF only.
ABC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.46  Med: 0.81 Max: 2.9
Current: 0.65
0.46
2.9
Price/DCF (Earnings Based) 1.17
ABC's Price/DCF (Earnings Based) is ranked higher than
80% of the 10 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.43 vs. ABC: 1.17 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.87
ABC's Price/Median PS Value is ranked higher than
70% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.98 vs. ABC: 0.87 )
Ranked among companies with meaningful Price/Median PS Value only.
ABC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.63  Med: 0.96 Max: 1.81
Current: 0.87
0.63
1.81
Earnings Yield (Greenblatt) (%) 8.10
ABC's Earnings Yield (Greenblatt) (%) is ranked higher than
67% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. ABC: 8.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ABC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.3  Med: 9.9 Max: 15
Current: 8.1
0.3
15
Forward Rate of Return (Yacktman) (%) 0.83
ABC's Forward Rate of Return (Yacktman) (%) is ranked lower than
76% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.44 vs. ABC: 0.83 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ABC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -20.1  Med: 16.5 Max: 29.5
Current: 0.83
-20.1
29.5

More Statistics

Revenue (TTM) (Mil) $146,850
EPS (TTM) $ 6.31
Beta0.81
Short Percentage of Float8.04%
52-Week Range $68.38 - 105.81
Shares Outstanding (Mil)220.10

Analyst Estimate

Sep17 Sep18 Sep19
Revenue (Mil $) 158,828 169,935 171,646
EPS ($) 5.83 6.41 6.89
EPS w/o NRI ($) 5.83 6.41 6.89
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($) 1.36 1.66 1.95
» More Articles for NYSE:ABC

Headlines

Articles On GuruFocus.com
Analysis of AmerisourceBergen's Dividend Increase Nov 17 2016 
Ray Dalio Raised Apple, Intel in 3rd Quarter Nov 16 2016 
Why Cardinal Health Is My Favorite Health Care Stock Nov 01 2016 
Guru Pain Is Your Gain in McKesson Oct 31 2016 
Healthcare Dividend Growth Stocks: Part 1 Aug 12 2016 
Van Den Berg's Best Investments of 2nd Quarter Aug 05 2016 
Healthcare Dividend Growth Stocks: Part 1 Aug 04 2016 
Sometimes It Is Good to Buy the Biggest. But Should You Buy the Biggest Health Care Distribution Bus Jul 29 2016 
Arnold Van Den Berg 2nd Quarter: Cuts Back on Gold Miners, Gets More Bullish on Oil Jul 25 2016 
Van Den Berg Made 6 New Buys in 2nd Quarter Jul 24 2016 

More From Other Websites
ETFs with exposure to AmerisourceBergen Corp. : December 8, 2016 Dec 08 2016
AmerisourceBergen Corp. : ABC-US: Dividend Analysis : November 21st, 2016 (record date) : By the... Dec 01 2016
AmerisourceBergen Corp. breached its 50 day moving average in a Bullish Manner : ABC-US : November... Nov 29 2016
ETFs with exposure to AmerisourceBergen Corp. : November 28, 2016 Nov 28 2016
AMERISOURCEBERGEN CORP Financials Nov 26 2016
AmerisourceBergen Corp. :ABC-US: Earnings Analysis: 2016 By the Numbers : November 25, 2016 Nov 25 2016
AMERISOURCEBERGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Nov 22 2016
AMERISOURCEBERGEN CORP Files SEC form 10-K, Annual Report Nov 22 2016
ETFs with exposure to AmerisourceBergen Corp. : November 16, 2016 Nov 16 2016
Suzuken Announces Decision to Use AmerisourceBergen’s Cubixx System to Enhance Specialty Drug... Nov 15 2016
AmerisourceBergen Corp. breached its 50 day moving average in a Bullish Manner : ABC-US : November... Nov 15 2016
Post Earnings Coverage as AmerisourceBergen Q4 Bottomline Outperformed Projections Nov 11 2016
AmerisourceBergen Increases Dividend 7 Percent Nov 10 2016
AmerisourceBergen Increases Dividend 7 Percent Nov 10 2016
AmerisourceBergen upgraded by Morgan Stanley Nov 10 2016
Jim Cramer's Top Takeaways: Chipotle, Merck, Pfizer Nov 10 2016
Jim Cramer's 'Mad Money' Recap: Willing Buyers Produce Improbable Rally Nov 09 2016
Why 'Gotham' And 'Agents Of SHIELD' Are In A Precarious Position Nov 04 2016
ETF’s with exposure to AmerisourceBergen Corp. : November 4, 2016 Nov 04 2016
AmerisourceBergen Corp. :ABC-US: Earnings Analysis: Q4, 2016 By the Numbers : November 3, 2016 Nov 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)